Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 1999, p. 1052-1061, Vol. 43, No. 5
Institute of
Parasitology,1 Department of Chemistry
and Biochemistry,2 and Department of
Clinical Pharmacology,
Received 2 December 1998/Returned for modification 20 January
1999/Accepted 10 February 1999
The metacestode stage of Echinococcus multilocularis is
the causative agent of alveolar echinococcosis (AE), a parasitic
disease affecting the liver, with occasional metastasis into other
organs. Benzimidazole carbamate derivatives such as mebendazole and
albendazole are currently used for chemotherapeutic treatment of AE.
Albendazole is poorly resorbed and is metabolically converted to its
main metabolite albendazole sulfoxide, which is believed to be the active component, and further to albendazole sulfone. Chemotherapy with
albendazole has been shown to have a parasitostatic rather than a
parasitocidal effect; it is not effective in all cases, and the
recurrence rate is rather high once chemotherapy is stopped. Thus,
development of new means of chemotherapy of AE is needed. This could
include modifications of benzimidazoles and elucidiation of the
respective biological pathways. In this study we performed in vitro
drug treatment of E. multilocularis metacestodes with albendazole sulfoxide and albendazole sulfone. High-performance liquid
chromatography analysis of vesicle fluids showed that the drugs were
taken up rapidly by the parasite. Transmission electron microscopic
investigation of parasite tissues and nuclear magnetic resonance
spectroscopy of vesicle fluids demonstrated that albendazole sulfoxide
and albendazole sulfone had similar effects with respect to parasite
ultrastructure and changes in metabolites in vesicle fluids. This study
shows that the in vitro cultivation model presented here provides an
ideal first-round test system for screening of antiparasite drugs.
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Efficacies of Albendazole Sulfoxide and Albendazole
Sulfone against In Vitro-Cultivated Echinococcus
multilocularis Metacestodes
*
Corresponding author. Mailing address: Institute of
Parasitology, University of Berne, Länggass-Strasse 122, CH-3012
Berne, Switzerland. Phone: (41) 31 6312384. Fax: (41) 31 6312622. E-mail: hemphill{at}ipa.unibe.ch.
Antimicrobial Agents and Chemotherapy, May 1999, p. 1052-1061, Vol. 43, No. 5
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»